Receptor, Biochemistry, Immunology, Molecular biology and Platelet-activating factor receptor are his primary areas of study. His work carried out in the field of Receptor brings together such families of science as Platelet-activating factor, Endocrinology and Kinase, Cell biology. His work on Enzyme, Pharmacological chaperone, Enzyme assay and Intracellular as part of general Biochemistry study is frequently linked to Migalastat, therefore connecting diverse disciplines of science.
His research investigates the link between Immunology and topics such as Lung that cross with problems in Pathogenesis and Respiratory distress. His Molecular biology research includes themes of 5-HT5A receptor, Signal transduction, G protein-coupled receptor and Lysophosphatidic acid, Autotaxin. His study looks at the intersection of Platelet-activating factor receptor and topics like Lipopolysaccharide with Lipid signaling, Biosynthesis and Acetyl-CoA.
His main research concerns Receptor, Cell biology, Platelet-activating factor receptor, Immunology and Platelet-activating factor. Satoshi Ishii combines subjects such as Molecular biology and Endocrinology with his study of Receptor. His research integrates issues of Platelet activation and Lysophosphatidic acid in his study of Cell biology.
His study in Platelet-activating factor receptor is interdisciplinary in nature, drawing from both Lipopolysaccharide, Methacholine, Microbiology, Genetically modified mouse and Neuroscience. His Immunology research integrates issues from Lung injury and Lung. His study looks at the relationship between Platelet-activating factor and topics such as Mediator, which overlap with Biological activity.
Satoshi Ishii focuses on Receptor, Cell biology, Lysophosphatidic acid, Internal medicine and Signal transduction. His Receptor research is under the purview of Biochemistry. His Cell biology research incorporates elements of Osteoclast, Gene mutation, Bone marrow and De novo synthesis.
His work carried out in the field of Lysophosphatidic acid brings together such families of science as Angiogenesis, T cell, Reticular cell, Immunology and Motility. In Internal medicine, Satoshi Ishii works on issues like Endocrinology, which are connected to Inflammation. As part of the same scientific family, Satoshi Ishii usually focuses on Platelet-activating factor, concentrating on Thermogenesis and intersecting with Platelet-activating factor receptor.
Satoshi Ishii mostly deals with Cell biology, Receptor, Signal transduction, Immunology and Lysophosphatidic acid. Satoshi Ishii interconnects Lung injury, Acyltransferases, Chinese hamster ovary cell and De novo synthesis in the investigation of issues within Cell biology. His Receptor research is mostly focused on the topic cAMP-dependent pathway.
His biological study spans a wide range of topics, including Optineurin and Cancer research. The concepts of his Immunology study are interwoven with issues in Keratinocyte activation, Chemotaxis and Lymph. His Lysophosphatidic acid study integrates concerns from other disciplines, such as G protein-coupled receptor, Lipid signaling, Gene knockdown, Sprouting angiogenesis and Notch signaling pathway.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.
Masato Iwabu;Toshimasa Yamauchi;Miki Okada-Iwabu;Koji Sato.
Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor.
Jian-Qiang Fan;Satoshi Ishii;Naoki Asano;Yoshiyuki Suzuki.
Nature Medicine (1999)
Role of cytosolic phospholipase A2 in allergic response and parturition.
Naonori Uozumi;Kazuhiko Kume;Takahide Nagase;Noriaki Nakatani.
Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family *
Kyoko Noguchi;Satoshi Ishii;Takao Shimizu.
Journal of Biological Chemistry (2003)
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice.
Satoshi Ishii;Takao Shimizu.
Progress in Lipid Research (2000)
In vitro inhibition and intracellular enhancement of lysosomal α-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives
Naoki Asano;Satoshi Ishii;Haruhisa Kizu;Kyoko Ikeda.
FEBS Journal (2000)
Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2.
Takahide Nagase;Naonori Uozumi;Satoshi Ishii;Kazuhiko Kume.
Nature Immunology (2000)
Impaired Anaphylactic Responses with Intact Sensitivity to Endotoxin in Mice Lacking a Platelet-activating Factor Receptor
Satoshi Ishii;Tomoyuki Kuwaki;Takahide Nagase;Kazushige Maki.
Journal of Experimental Medicine (1998)
Platelet-Activating Factor Receptor
Zen-ichiro Honda;Satoshi Ishii;Takao Shimizu.
Journal of Biochemistry (2002)
Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell Mobilization
Véronique Angeli;Jaime Llodrá;James X. Rong;Kei Satoh.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: